Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: EMN stock price vs CL: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CL's multiple
Needs CL P/E.
Implied fair value · at EMN's multiple
Needs EMN P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
16 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
EASTMAN CHEMICAL CO · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
COLGATE-PALMOLIVE COMPANY · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Celanese Corp
EMN vs CE
DuPont de Nemours, Inc.
EMN vs DD
ALBEMARLE CORP
EMN vs ALB
LyondellBasell Industries N.V.
EMN vs LYB
ECOLAB INC.
EMN vs ECL
PPG INDUSTRIES INC
EMN vs PPG
PROCTER & GAMBLE Co
EMN vs PG
JOHNSON & JOHNSON
EMN vs JNJ
CHURCH & DWIGHT CO INC /DE/
EMN vs CHD
KIMBERLY CLARK CORP
EMN vs KMB
EDGEWELL PERSONAL CARE Co
EMN vs EPC
UNILEVER PLC
EMN vs UL
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe EMN can re-accelerate growth and sustain margins despite its negative revenue trend, then EMN looks attractive versus the P/E-based CL valuation because it trades at a large multiple discount and near the bottom of its historical range.
EMN trades at $69.95 versus a P/E-implied value of $142.33, implying 103.5% upside on that method. However, CL-implied range and EMN's own historical/DCF bands suggest the stock is already near the lower end of more conservative valuation frameworks.
Supporting Metrics
